T. Rowe Price Investment Management, Inc.

Position in JNJ — Johnson & Johnson

CIK 1897612 BALTIMORE, MD

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,987,208

+$850,061 QoQ

Shares Held

19,637

+16.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,621

of 4,680 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

T. Rowe Price Investment Management, Inc. holds $130,347,685 across 8 Drug Manufacturers - General names. JNJ ranks #4 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	50,482	$60,549,630
2	GILD	Gilead Sciences, Inc.	276,379	$34,917,722
3	BIIB	Biogen Inc.	113,873	$24,603,400
4	JNJ	Johnson & Johnson This page	19,637	$4,987,208
5	ABBV	AbbVie Inc.	5,805	$1,460,770
6	BMY	Bristol Myers Squibb Co	24,400	$1,405,928
7	PFE	Pfizer Inc	56,140	$1,351,851
8	MRK	Merck & Co., Inc.	8,336	$1,071,176

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,987,208	19,637	+16.0%	Shares	Sole	2026-08-14
2026-03-31	$4,137,147	16,925	+21.8%	Shares	Sole	2026-05-15
2025-12-31	$2,876,605	13,900	+84.4%	Shares	Sole	2026-02-17
2025-09-30	$1,397,325	7,536	-98.8%	Shares	Sole	2025-11-14
2025-06-30	$95,772,722	626,990	+1.5%	Shares	Sole	2025-08-14
2025-03-31	$102,459,932	617,824	+25815.4%	Shares	Sole	2025-05-14
2024-06-30	$348,445	2,384	0.0%	Shares	Sole	2024-08-14
2024-03-31	$377,124	2,384	+30.4%	Shares	Sole	2024-05-15
2023-12-31	$286,520	1,828	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.